1. Home
  2. Nation
  3. Centre close to giving indemnity to foreign Covid vaccine makers like Pfizer: Reports

Centre close to giving indemnity to foreign Covid vaccine makers like Pfizer: Reports

By Saima Siddiqui 
Updated Date
Centre close to giving indemnity to foreign Covid vaccine makers like Pfizer: Reports

New Delhi: Government is reportedly having a change of heart and is likely to grant foreign Covid-19 vaccine makers such as Pfizer Inc protection against legal liability so that they can use their shots in an immunisation campaign that is facing acute shortages, three government sources told media.

Also Read :- Delhi scales up Oxygen capacity as CM Kejriwal warns of 3rd Covid wave

“Indemnity will be granted,” said one of the sources. “If one company gets it then all of them get it.”

It is to be mentioned that India invited Pfizer, Moderna and Johnson & Johnson in April to sell their vaccines after infections rates rocked the country. However, no deal has yet been signed.

Pfizer has not sold to any country without obtaining indemnity against legal action over any adverse effects of their product. While, India has not granted indemnity to any Covid-19 vaccine maker, but the sources, who requested anonymity, said the government is giving it a thought.

The government has already met one of Pfizer’s other key demands by dropping a requirement that foreign vaccines undergo local trials.

Also Read :- Covid-19 'Delta' variant can be the reason for the 2nd wave in India: Study

Another government official said he expected Pfizer vaccines to be delivered in August. He said initial recipients of foreign shots could be monitored, before a mass roll-out “once we are sure of its efficacy on Indians.”

Pfizer declined to comment on its discussions with the Indian government but said it sought indemnity wherever it supplied its vaccine.

“We seek the same kind of indemnity and liability protections in all of the countries that have asked to purchase our vaccine, consistent with the local applicable laws to create the appropriate risk protection for all involved,” a Pfizer spokeswoman said in an email to Reuters.

One of the sources said India was negotiating prices of $10-$12 per dose for foreign shots. The European Union is paying 15.5 euros ($18.86) per dose for the Pfizer vaccine developed with Germany’s BioNTech.

The Pfizer spokeswoman said the company had offered doses to many countries at a not-for-profit price.

Also Read :- India reports 84,332 new COVID-19 cases in lowest single-day rise in 70 days

So far, India has administered more than 239 million vaccine doses – mainly a licensed version of the AstraZeneca drug produced indigenously – the most in the world after China and the United States. But with a population of 1.35 billion people, India’s vaccination rate is much lower than many other countries.

Further reading:
For the latest news and reviews, follow us on Facebook and Twitter ...